1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Opioid Withdrawal: new trials by email Literature Review of Opioid Withdrawal trials Research Report on Opioid Withdrawal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD Pramipexole, Placebo - Sleep Disorder, Restless Legs Syndrome | Phase 2 / Phase 3 | Terminated | Massachusetts General Hospital | 75 | 2022-01-24 | 2025-09-22 |
Opioid-Related Disorders (1) · Restless Legs Syndrome (1) · Sleep Wake Disorders (1)
Chemically-Induced Disorders (1) · Dyssomnias (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Parasomnias (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Sleep Disorders, Intrinsic (1) · Substance-Related Disorders (1)
Pramipexole (1)
Massachusetts General Hospital (1)
United States (1)
R21DA052861 (1)